PRICE T ROWE ASSOCIATES INC /MD/ - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 25 filers reported holding APTEVO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16
-76.5%
46,2000.0%0.00%
Q2 2023$68
-28.4%
46,2000.0%0.00%
Q1 2023$95
-11.2%
46,2000.0%0.00%
Q4 2022$107
-99.9%
46,2000.0%0.00%
Q3 2022$141,000
-14.5%
46,2000.0%0.00%
Q2 2022$165,000
-39.1%
46,2000.0%0.00%
Q1 2022$271,000
-25.5%
46,2000.0%0.00%
Q4 2021$364,000
+57.6%
46,200
+633.3%
0.00%
Q4 2020$231,0006,3000.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$64,504,0009.85%
Stonepine Capital Management, LLC 18,280$670,0000.51%
Ghost Tree Capital, LLC 50,000$1,833,0000.41%
Anson Funds Management LP 45,462$1,666,0000.34%
RTW INVESTMENTS, LP 288,236$10,564,0000.18%
Dynamic Technology Lab Private Ltd 13,202$484,0000.08%
Alyeska Investment Group, L.P. 49,601$1,818,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 11,493$421,0000.02%
PURA VIDA INVESTMENTS, LLC 8,203$301,0000.01%
Renaissance Technologies 254,423$9,325,0000.01%
View complete list of APTEVO THERAPEUTICS INC shareholders